Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: The Nordic experience of 2648 patients diagnosed between 1981 and 1996

Acta Paediatrica, International Journal of Paediatrics

Volumn 87, Issue 11, 1998, Pages 1151-1161

  Gustafsson, G ^a   Kreuger, A ^b   Clausen, N ^c   Garwicz, S ^d   Kristinsson, J ^e   Lie, S O ^f   Moe, P J ^g   Perkkio M ^h   Yssing, M ^a,i   Saarinenpihkala, U M ^j  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

^g TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^h KUOPIO UNIVERSITY HOSPITAL   (Finland)

ⁱ Rigshospitalet   (Denmark)

^j UNIVERSITY OF HELSINKI   (Finland)

more..

Author keywords

Childhood acute lymphoblastic leukaemia; Incidence; Prognosis in childhood acute lymphoblastic leukaemia; Prognostic factors; Treatment results

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; FOLINIC ACID; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; B CELL LEUKEMIA; BRAIN RADIATION; CANCER INCIDENCE; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CLINICAL PROTOCOL; CONTROLLED STUDY; DENMARK; DRUG MEGADOSE; FEMALE; FINLAND; HUMAN; ICELAND; INFANT; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NORWAY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SWEDEN;

EID: 0031766687     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1998.tb00923.x     Document Type: Article

References (23)

1. Pinkel D, Simone J, Hustu O, Auer RJA. Nine years experience with total therapy of childhood acute lymphoblastic leukaemia. Pediatrics 1972; 50: 246-90
2. Reiter A, Schrappe M, Ludwig WD, Hiddemann \V, Sauter S, Henze G, et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukaemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 1994; 84: 3122-30
3. Gustafsson G, Garwicz S, Hertz H, Johannesson G, Jonmundsson G, Moe PJ, et al for NOPHO. A population-based study of childhood acute lymphoblastic leukaemia diagnosed from July 1981 through June 1985 in the five Nordic countries. Acta Paediatr Scand 1987; 76:781-8
4. Riehm H, Gadner H, Henze G, Kornhuber B, Lampert F, Niethammar D, et al. Results and significance of six randomised trials in four consecutive ALL-BFM studies. Haematol Blood Transfus 1990; 33: 439-50
5. Wollner N, Exilby PR, Liebermann P. Non Hodgkin's lymphoma in children. Cancer 1979; 44: 1990-9
6. Riehm H, Feickert H, Lampert F. Acute lymphoblastic leukemia. In: Voute PA, Barret A, Bloom HJG, Lemerle J, Neidhart MK, editors. Cancer in children: clinical management. Heidelberg: Springer, 1986: 101-18
7. SPSS statistical software. SPSS: Base 8.0 and Advanced Statistics 8.0 for Windows. Chicago, IL: SPSS, 1998
8. Cox DR. Regression models and life tables. J R Stat Soc (B) 1972; 34: 187-220
9. Gustafsson G, Berglund G, Garwicz S, Hertz H, Jonmundsson G, Moe PJ, et al for NOPHO. A population-based study of children with standard risk acute lymphoblastic leukaemia in the five Nordic countries. Acta Paediatr Scand 1989; 78: 104-9
10. Lanning M, Garwicz S, Hertz H, Jonmundsson G, Kreuger A, Lie SO, et al. Superior treatment results in females with high-risk acute lymphoblastic leukaemia in childhood. Acta Paediatr 1992; 81:66-8
11. Schröder H, Garwicz S, Kristinsson J, Siiemes MA, Wesenberg F, Gustafsson G, on behalf of NOPHO. Outcome after first relapse in children with acute lymphoblastic leukaemia. Med Pediatr Oncol 1995; 25: 372-8
12. Pui CH. Childhood leukaemia. New Engl J Med 1995; 332: 1618-30
13. Moe PJ, Seip M, Finne PH. Intermediate dose methotrexate in childhood acute lymphocytic leukaemia. Acta Paediatr Scand. 1981; 70:73-6
14. Veerman AJP, Hählen K, Kamps WA, van Leeuwen E, de Vaan G, Solbu G, et al. High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukaemia: results of protocol ALL VI from the Dutch Childhood Leukaemia Study group. J Clin Oncol 1996; 14: 911-8
15. Kreuger A, Garwicz S, Hertz H, Jonmundsson G, Lanning M, Lie SO, et al. CNS disease in childhood acute lymphoblastic leukaemia. Prognostic factors and treatment results. Pediatr Hematol Oncol 1991:8:291-9
16. Moe PJ. Recent advances in the management of acute lymphocytic leukaemia. Eur Paediatr Haematol Oncol 1984; 1: 19-22
17. Moe PJ, Wesenbcrg F, Kolmannskog S. Methotrexate infusions in poor prognosis acute lymphocytic leukaemia: II. High dose methotrexate (HDM) in acute lymphocytic leukaemia in childhood. A pilot study from 1981. Med Pediatr Hematol Oncol 1986; 14: 187-8
18. Forestier E, Gustafsson G, von Heideman A, Heim S, Hernell O, Mitelman F, et al. Prognostic impact of bone marrow karyotype in childhood acute lymphoblastic leukaemia: Swedish experiences 1986-91. Acta Paediatr 1997; 86: 819-25
19. Saarinen U, Mellander L, Nystrom K, Ringden O, Schroeder H, Glomstein A, Gustafsson G. Allogeneic bone marrow transplantation in first remission for children with very high-risk acute lymphoblastic leukaemia: a retrospective case-control study in the Nordic countries. Bone Marrow Transplant 1996; 17: 357-63
20. Steinhertz P, Gaynon P, Breneman J, Cherlow J, Grossman N, Kersey J, et al. Cytoreduction and prognosis in acute lymphoblastic leukaemia-the importance of early marrow response. Report from the Children's Cancer Group. J Clin Oncol 1996; 14: 389-98
21. Jacquy C, Delepaut B, van Daeles S, Vaerman JL, Zeneberg A, Brichard B, et al. A prospective study of minimal residual disease in childhood B-linkage acute lymphoblastic leukaemia: MRD levels at the end of induction is a strong predictive factor of relapse. Br J Haematol 1997; 98: 140-6
22. Kaspers GJ, Veerman AJ, Pieters R, Van Zantwijk CH, Smets LA, Van Wering RE, et al. In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukaemia. Blood 1997; 90: 2723-9
23. Lowdell M, Craston R, Prentice G. Understanding towards the immunotherapy of leukaemia. Hematology 1997; 2: 193-201